(KMB) Kimberly-Clark - NASDAQ
Sector: Consumer Defensive | Industry: Household & Personal Products | Exchange: NASDAQ (USA) | Market Cap: 33.705m USD | Total Return: -17.9% in 12m
Avg Turnover: 410M
EPS Trend: 76.6%
Qual. Beats: 0
Rev. Trend: -96.2%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Kimberly-Clark Corporation (KMB) is a global manufacturer of essential personal care and tissue products, operating primarily through its North America and International Personal Care segments. Its portfolio includes household brands such as Huggies, Kleenex, Scott, and Kotex, which are distributed via retail channels, e-commerce, and professional distributors.
The company operates within the consumer staples sector, a category characterized by inelastic demand as consumers typically prioritize hygiene and paper products regardless of economic cycles. Kimberly-Clark utilizes a high-volume manufacturing model that relies on global supply chains for raw materials like wood fiber and polymer resins. For a deeper look at the company’s fundamental health, consider reviewing the latest metrics on ValueRay.
Founded in 1872 and headquartered in Dallas, Texas, the firm maintains a dual-track sales strategy targeting both individual consumers and institutional clients, including the lodging, food service, and office building industries.
- Raw material costs for pulp and polymers dictate quarterly operating margins
- Market share growth for Huggies and Kleenex drives organic revenue expansion
- Strategic restructuring and supply chain optimization fuel long-term productivity gains
- Consumer trade-down to private labels threatens North American premium brand volume
- Emerging market penetration in Latin America and Asia supports international segment growth
| Net Income: 2.12b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 0.33 > 1.0 |
| NWC/Revenue: -9.75% < 20% (prev -9.04%; Δ -0.71% < -1%) |
| CFO/TA 0.19 > 3% & CFO 3.19b > Net Income 2.12b |
| Net Debt (6.67b) to EBITDA (3.06b): 2.18 < 3 |
| Current Ratio: 0.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (333.2m) vs 12m ago -0.03% < -2% |
| Gross Margin: 35.86% > 18% (prev 36.19%; Δ -0.33% > 0.5%) |
| Asset Turnover: 98.77% > 50% (prev 111.3%; Δ -12.50% > 0%) |
| Interest Coverage Ratio: 9.67 > 6 (EBIT TTM 2.42b / Interest Expense TTM 250.0m) |
| A: -0.09 (Total Current Assets 5.29b - Total Current Liabilities 6.90b) / Total Assets 17.2b |
| B: 0.57 (Retained Earnings 9.85b / Total Assets 17.2b) |
| C: 0.14 (EBIT TTM 2.42b / Avg Total Assets 16.7b) |
| D: 0.12 (Book Value of Equity 1.80b / Total Liabilities 15.3b) |
| Altman-Z'' = 2.35 = BBB |
| DSRI: 1.01 (Receivables 2.00b/2.18b, Revenue 16.5b/18.1b) |
| GMI: 1.01 (GM 36.19% / 35.86%) |
| AQI: 1.37 (AQ_t 0.29 / AQ_t-1 0.22) |
| SGI: 0.91 (Revenue 16.5b / 18.1b) |
| TATA: -0.06 (NI 2.12b - CFO 3.19b) / TA 17.2b) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of June 15, 2026, the stock is trading at USD 102.29 with a total of 3,462,610 shares traded.
Over the past week, the price has changed by +3.28%,
over one month by +7.27%,
over three months by +3.43% and
over the past year by -17.89%.
Kimberly-Clark has received a consensus analysts rating of 3.44. Therefore, it is recommended to hold KMB.
- StrongBuy: 3
- Buy: 3
- Hold: 9
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 114.3 | 11.7% |
P/E Trailing = 19.6402
P/E Forward = 13.5501
P/S = 2.0358
P/B = 18.7742
P/EG = 2.0521
Revenue TTM = 16.5b USD
EBIT TTM = 2.42b USD
EBITDA TTM = 3.06b USD
Long Term Debt = 6.47b USD (from longTermDebt, last quarter)
Short Term Debt = 609.0m USD (from shortTermDebt, last quarter)
Debt = 7.21b USD (from shortLongTermDebtTotal, last quarter) + Leases 128.0m
Net Debt = 6.67b USD (calculated: Debt 7.21b - CCE 542.0m)
Enterprise Value = 40.4b USD (33.7b + Debt 7.21b - CCE 542.0m)
Interest Coverage Ratio = 9.67 (Ebit TTM 2.42b / Interest Expense TTM 250.0m)
EV/FCF = 15.66x (Enterprise Value 40.4b / FCF TTM 2.58b)
FCF Yield = 6.39% (FCF TTM 2.58b / Enterprise Value 40.4b)
FCF Margin = 15.59% (FCF TTM 2.58b / Revenue TTM 16.5b)
Net Margin = 12.81% (Net Income TTM 2.12b / Revenue TTM 16.5b)
Gross Margin = 35.86% ((Revenue TTM 16.5b - Cost of Revenue TTM 10.6b) / Revenue TTM)
Gross Margin QoQ = 36.85% (prev 35.91%)
Tobins Q-Ratio = 2.35 (Enterprise Value 40.4b / Total Assets 17.2b)
Interest Expense / Debt = 3.47% (Interest Expense 250.0m / Debt 7.21b)
Taxrate = 23.63% (526.0m / 2.23b)
NOPAT = 1.85b (EBIT 2.42b * (1 - 23.63%))
Current Ratio = 0.77 (Total Current Assets 5.29b / Total Current Liabilities 6.90b)
Debt / Equity = 4.02 (Debt 7.21b / totalStockholderEquity, last quarter 1.80b)
Debt / EBITDA = 2.18 (Net Debt 6.67b / EBITDA 3.06b)
Debt / FCF = 2.59 (Net Debt 6.67b / FCF TTM 2.58b)
Total Stockholder Equity = 1.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.65% (Net Income 2.12b / Total Assets 17.2b)
RoE = 143.6% (Net Income TTM 2.12b / Total Stockholder Equity 1.48b)
RoCE = 30.41% (EBIT 2.42b / Capital Employed (Equity 1.48b + L.T.Debt 6.47b))
RoIC = 17.85% (NOPAT 1.85b / Invested Capital 10.3b)
WACC = 5.19% (E(33.7b)/V(40.9b) * Re(5.74%) + D(7.21b)/V(40.9b) * Rd(3.47%) * (1-Tc(0.24)))
Discount Rate = 5.74% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.01 | Cagr: -0.76%
[DCF] Terminal Value 76.41% ; FCFF base≈2.50b ; Y1≈2.68b ; Y5≈3.21b
[DCF] Fair Price = 128.5 (EV 49.3b - Net Debt 6.67b = Equity 42.6b / Shares 331.9m; r=8.35% [WACC [floored]]; 5y FCF grow 7.78% → 2.50% )
EPS Correlation: 76.58 | EPS CAGR: 4.74% | SUE: 0.26 | # QB: 0
Revenue Correlation: -96.21 | Revenue CAGR: -7.40% | SUE: 0.13 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.02 | Chg30d=+0.00% | Revisions=-73% | Analysts=13
EPS next Quarter (2026-09-30): EPS=1.81 | Chg30d=+0.00% | Revisions=-12% | Analysts=13
EPS current Year (2026-12-31): EPS=7.54 | Chg30d=+0.00% | Revisions=+18% | GrowthEPS=+0.1% | GrowthRev=+3.3%
EPS next Year (2027-12-31): EPS=7.58 | Chg30d=+0.46% | Revisions=-7% | GrowthEPS=+0.5% | GrowthRev=+3.5%
[Analyst] Revisions Ratio: -73%